TrialAmerican journal of hematology2015

Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: A Phase III international randomized clinical trial.

Jane S Hankins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.